INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Gut Microbiome desk →

830 studies · page 24 of 35

2021 / Interventional trial and metagenomic reanalysis

Probiotics exerted person-specific and antibiotic-dependent effects on the gastrointestinal tract resistome.

Researchers analyzed gut metagenomes from healthy antibiotic-naïve humans supplemented with an 11-probiotic-strain preparation, alongside mouse models and a separate human cohort receiving antibiotics. Probiotics reduced the number of antibiotic resistance genes exclusively in the gut of colonization-permissive, antibiotic-naïve individuals. Following antibiotics, probiotics exacerbated resistome expansion in GI mucosa by supporting a bloom of strains with vancomycin resistance genes, unlike autologous fecal microbiome transplantation or spontaneous recovery. These mucosal effects were not reflected in stool samples.

Montassier E, Valdés-Mas R, Batard E, et al. Nat Microbiol, 2021. PMID 34226711

2020 / Crossover feeding trial

A 5-day isocaloric high-fat diet doubled fasting endotoxin and altered skeletal muscle substrate metabolism without altering gut permeability in young men.

Thirteen healthy young men consumed a control diet for 2 weeks followed by 5 days of an isocaloric high-fat diet (HFD; 55% fat, 25% saturated). Intestinal permeability and responses to a high-fat meal challenge were evaluated before and after the HFD. Intestinal permeability was not affected by the HFD (p > 0.05), but fasting endotoxin increased two-fold (p = 0.04). Skeletal muscle glucose and fatty acid oxidation increased post-meal before the HFD (+97% and +106%) but decreased post-meal after the HFD (-24% and +16%, respectively), while insulin sensitivity remained unchanged.

Bowser SM, McMillan RP, Boutagy NE, et al. Metabolism, 2020. PMID 31785256

2020 / Crossover clinical trial

Extra virgin olive oil reduced inflammatory markers and digestive symptoms in patients with ulcerative colitis

In a crossover clinical trial comparing extra virgin olive oil with canola oil, 32 of 40 patients with ulcerative colitis completed two 20-day intervention rounds. Consumption of extra virgin olive oil was followed by significant decreases in erythrocyte sedimentation rate (p = 0.03) and high-sensitivity C-reactive protein (p < 0.001). Bloating, constipation, fecal urgency, incomplete defecation, and final gastrointestinal symptom rating scale scores were also significantly reduced after extra virgin olive oil consumption (p < 0.05).

NANO counterpoint →

Morvaridi M, Jafarirad S, Seyedian SS, et al. Eur J Clin Nutr, 2020. PMID 31901082

2020 / Randomized double-blind placebo-controlled pilot trial

Weekly oral fecal microbiota transplantation from lean donors did not significantly improve insulin sensitivity or body composition in adults with obesity.

In a 12-week pilot trial, 24 adults with obesity and mild-moderate insulin resistance were randomized to weekly oral FMT capsules from healthy lean donors or placebo for 6 weeks. There were no statistically significant improvements in insulin sensitivity between groups (+5% ± 12% in FMT vs -3% ± 32% in placebo, mean difference 9%, 95% CI -5% to 28%, p = 0.16). Additionally, no significant differences were seen for HOMA-IR (mean difference 0.2, 95% CI -0.9 to 0.9, p = 0.96), lean mass (mean difference -0.1 kg, p = 0.87), or fat mass (mean difference 1.2 kg, p = 0.18). Variable bacterial engraftment persisted throughout 12 weeks with no serious adverse events related to FMT.

Yu EW, Gao L, Stastka P, et al. PLoS Med, 2020. PMID 32150549

2020 / Randomized controlled trial

Flaxseed flour supplementation improved constipation symptoms and quality of life more effectively than lactulose in Chinese adults.

A randomized controlled trial evaluated 90 adults with functional constipation assigned to receive either 50 g/day flaxseed flour (n=60) or 15 mL/day lactulose solution (n=30) for 4 weeks. Both groups showed significant improvements in bowel habits. Median Wexner constipation scores fell from 14 to 6.5 in the flaxseed group and 15 to 9 in the lactulose group (both p<0.001). Median weekly defecation frequency rose from 2 to 7 with flaxseed and 2 to 6 with lactulose (both p<0.001), while constipation quality of life scores dropped by -1.34 and -0.66, respectively (both p<0.001).

Sun J, Bai H, Ma J, et al. Asia Pac J Clin Nutr, 2020. PMID 32229443

2019 / Randomized controlled trial

Prunes increased stool weight and frequency in healthy adults with low fiber intake.

In a 4-week trial of 120 healthy adults, consuming 80 g/d or 120 g/d of prunes led to significantly greater increases in daily stool weight (+22.2 g/d and +32.8 g/d, respectively) versus control (-0.8 g/d, P = 0.026). Stool frequency was also significantly higher (P = 0.023), with increased Bifidobacteria across groups (P = 0.046) and increased flatulence. Prunes showed no effect on whole gut transit time, short-chain fatty acids, or stool pH.

Lever E, Scott SM, Louis P, et al. Clin Nutr, 2019. PMID 29398337

2019 / Randomized controlled trial

Intragastric quinine decreased ghrelin, motilin, prospective food consumption, and hedonic food intake in healthy women.

In 15 healthy women, brain responses to intragastric quinine-hydrochloride (10 µmol/kg) or placebo infusion were recorded using fMRI alongside appetite-related sensations, gastrointestinal hormones, and hedonic food intake. Quinine administration lowered octanoylated ghrelin (P<0.04), total ghrelin (P<0.01), and motilin (P<0.01) plasma levels, alongside lower prospective food consumption ratings (P<0.02) and hedonic food intake (P<0.05). Quinine also increased neural activity in the hypothalamus and hedonic brain regions but decreased activity in the homeostatic medulla (all pFWE-corrected<0.05).

Iven J, Biesiekierski JR, Zhao D, et al. Nutr Neurosci, 2019. PMID 29607741

2019 / Randomized controlled trial

Flixweed and fig improved several constipation-predominant irritable bowel syndrome symptoms.

In a randomized trial, 150 patients with constipation-predominant irritable bowel syndrome consumed flixweed, fig, or control interventions for 4 months. Both flixweed and fig led to significant improvements in pain frequency, distention, defecation frequency, hard stool, quality of life, and bowel habit satisfaction compared to control. Neither intervention significantly altered C-reactive protein concentrations or the intensity of abdominal pain.

Pourmasoumi M, Ghiasvand R, Darvishi L, et al. Explore (NY), 2019. PMID 30318190

2019 / Prospective crossover study

Using a defecation posture modification device reduced straining and bowel movement duration while increasing bowel emptiness.

A prospective crossover study tracked real-time bowel movement data in 52 volunteers over 4 weeks (2 weeks without a defecation postural modification device [DPMD] followed by 2 weeks with DPMD). Across 1119 recorded bowel movements, utilizing the DPMD resulted in increased bowel emptiness (OR 3.64; 95% CI, 2.78-4.77) and reduced straining (OR 0.23; 95% CI, 0.18-0.30). Furthermore, not using the DPMD was associated with increased bowel movement duration (fold increase 1.25; 95% CI, 1.17-1.33).

Modi RM, Hinton A, Pinkhas D, et al. J Clin Gastroenterol, 2019. PMID 30346317

2019 / Clinical trial

Omnivorous diets induce gut microbial pathways that convert dietary l-carnitine into proatherogenic TMAO.

Researchers evaluated isotope-labeled l-carnitine and gamma-butyrobetaine metabolism in 40 omnivores and 32 vegans or vegetarians. Following oral d3-l-carnitine, omnivores generated over 20-fold more d3-TMAO than vegans or vegetarians (P = 0.001), despite comparable fasting plasma carnitine levels. Gut bacteria transformed carnitine into gamma-butyrobetaine in both dietary groups, but conversion of gamma-butyrobetaine to TMA was induced by chronic carnitine intake and omnivorous habits.

Koeth RA, Lam-Galvez BR, Kirsop J, et al. J Clin Invest, 2019. PMID 30530985

2019 / Three-group randomized crossover trial

A plant-based tofu meal increased satiety and gut hormones more than a matched processed-meat and cheese meal across healthy, obese, and diabetic men.

Researchers evaluated the acute effects of two energy- and macronutrient-matched meals—a vegan meal with tofu (V-meal) versus a processed-meat and cheese meal (M-meal)—in men with type 2 diabetes, obese men, and healthy men (n=20 each). Postprandial GLP-1 secretion increased after the V-meal in diabetic men (by 30.5%) and healthy men (by 15.8%), while amylin increased across all groups (diabetic by 15.7%, obese by 11.5%, healthy by 13.8%). Postprandial PYY increased significantly only in healthy men (by 18.9%). Satiety was higher after the V-meal in all groups: by 9% in diabetic, 18.7% in obese, and 25% in healthy men.

Klementova M, Thieme L, Haluzik M, et al. Nutrients, 2019. PMID 30642053

2019 / Single-blinded randomized controlled trial

Flaxseed and psyllium improved constipation symptoms, weight, glycemia, and lipids compared to placebo in constipated patients with type 2 diabetes.

In a 12-week single-blinded trial, 77 constipated patients with type 2 diabetes received cookies containing 10 g flaxseed, 10 g psyllium, or placebo twice daily. Compared to placebo, both flaxseed and psyllium groups showed significant improvements from baseline in constipation symptoms (P = 0.002), stool consistency (P < 0.001), weight (P < 0.001), BMI (P < 0.001), fasting plasma glucose (P = 0.004), cholesterol (P = 0.010), LDL cholesterol (P = 0.031), and cholesterol/HDL cholesterol ratio (P = 0.019). Flaxseed appeared superior to psyllium for improving these markers, and no adverse effects were observed.

Soltanian N, Janghorbani M Clin Nutr ESPEN, 2019. PMID 30661699

2019 / Two randomized, placebo-controlled, double-blind trials

Psyllium supplementation altered stool microbiota and increased stool water, with more pronounced microbiota changes observed in constipated patients.

Two randomized, placebo-controlled, double-blind trials evaluated 7 days of psyllium versus maltodextrin placebo in 8 healthy volunteers and 16 constipated patients. In healthy adults, psyllium had a small effect on microbiota (increasing Veillonella and decreasing Subdoligranulum), while constipated patients showed greater changes (increased Lachnospira, Faecalibacterium, Phascolarctobacterium, Veillonella, and Sutterella; decreased uncultured Coriobacteria and Christensenella) and altered acetate and propionate levels. Furthermore, increases in three butyrate-producing genera (Lachnospira, Roseburia, and Faecalibacterium) correlated with increased faecal water.

Jalanka J, Major G, Murray K, et al. Int J Mol Sci, 2019. PMID 30669509

2019 / Randomized controlled trial

Diets differing in fat content altered gut bacteria and fecal metabolites

A 6-month feeding trial assigned 217 healthy young adults to lower-fat (20% energy), moderate-fat (30%), or higher-fat (40%) diets. The lower-fat diet was associated with increased alpha-diversity (p = 0.03) and higher abundance of Blautia and Faecalibacterium. Conversely, the higher-fat diet was associated with decreased total short-chain fatty acids (p < 0.001), reduced Faecalibacterium, enriched fecal arachidonic acid, and higher plasma proinflammatory markers.

Wan Y, Wang F, Yuan J, et al. Gut, 2019. PMID 30782617

2019 / Randomized controlled trial

Reducing red and processed meat intake did not lower Crohn's disease relapse rates.

In a randomized trial, 214 adults with Crohn's disease in remission consumed either at least two weekly servings of red or processed meat (n = 118) or maximum one monthly serving (n = 96) for 49 weeks. Symptomatic relapse occurred in 62% of the high-meat participants and 42% of the low-meat cohort. Time to any relapse (P = 0.61) or moderate-to-severe relapse (P = 0.50) did not vary significantly between the dietary arms.

NANO counterpoint →

Albenberg L, Brensinger CM, Wu Q, et al. Gastroenterology, 2019. PMID 30872105

2019 / Two-year follow-up of an open-label clinical trial

Two years after Microbiota Transfer Therapy, participants with ASD maintained GI improvements, showed further autism symptom gains, and sustained gut changes.

Researchers conducted a two-year follow-up of 18 participants with Autism Spectrum Disorders who previously completed an open-label trial of Microbiota Transfer Therapy (MTT) combining antibiotics, bowel cleanse, acid suppressant, and fecal microbiota transplant. Most improvements in gastrointestinal symptoms were maintained, and autism-related symptoms improved further two years after treatment ended. Important gut microbiota changes persisted, including significant increases in bacterial diversity and relative abundances of Bifidobacteria and Prevotella.

Kang DW, Adams JB, Coleman DM, et al. Sci Rep, 2019. PMID 30967657

2019 / Single-group trial / case series

Hospitalized ulcerative colitis patients receiving a plant-based diet showed low relapse rates.

A lacto-ovo-semivegetarian regimen was integrated into induction therapy for 92 patients hospitalized with ulcerative colitis. Cumulative relapse rates were 14% at 1 year and 27% at 5 years for initial episode cases, and 36% at 1 year and 53% at 5 years for relapse cases. At a mean follow-up of 6 years and 4 months, adherence measured by the plant-based diet score remained significantly higher than baseline (p < 0.0001).

Chiba M, Nakane K, Tsuji T, et al. Perm J, 2019. PMID 31050638

2019 / Prospective endoscopic challenge study

In patients with IBS, endoscopic challenge with food antigens triggered non-IgE-associated barrier disruption and eosinophil activation in over 50% of cases.

A prospective study challenged 155 patients with IBS using 4 common food components via endoscope followed by confocal laser endomicroscopy (CLE), alongside duodenal biopsy and fluid analysis. Of the 108 patients who completed the study, 76 (70%) had a response to food (CLE+), with 61% of these reacting to wheat. CLE+ patients had significantly higher intraepithelial lymphocytes (P = .001), up-regulated claudin-2 (P = .023), lower occludin levels (P = .022), increased eosinophil degranulation, and higher eosinophilic cationic protein in duodenal fluid (P = .03) compared to controls. Inflammatory cytokine messenger RNA levels remained unchanged after challenge.

Fritscher-Ravens A, Pflaum T, Mösinger M, et al. Gastroenterology, 2019. PMID 31100380

2019 / Pilot study

In patients with metabolic syndrome, blueberry-enriched meals shifted postprandial urinary metabolites and reduced IL-6 while increasing TGF-β expression.

A pilot study evaluated the postprandial effects of high-fat/high-glycemic load meals enriched with blueberries in 5 obese/overweight patients with metabolic syndrome. Significant decreases in urinary methylamines, acetoacetate, acetone, and succinate were observed at 2 and 4 hours post-ingestion, alongside accumulation of gut-derived phenolic acids. In mononuclear blood cells, mRNA expression of interleukin-6 significantly decreased and transforming growth factor-β significantly increased following blueberry supplementation.

Sobolev AP, Ciampa A, Ingallina C, et al. Metabolites, 2019. PMID 31295937

2019 / Prospective intervention study with a matched control group

TMAO and its precursors were elevated in PCOS and decreased after 3 months of oral contraceptive use paired with general dietary advice.

Researchers compared 27 overweight/obese women with PCOS to 25 matched controls after a 3-day standardized diet, followed by a 3-month oral contraceptive (OC) intervention with dietary advice in the PCOS group. At baseline, the PCOS group showed significantly higher serum levels of TMAO, choline, betaine, and carnitine, with TMAO and choline correlating with total testosterone. Following the 3-month OC therapy and lifestyle intervention, TMAO and its precursors significantly decreased alongside reductions in BMI, total testosterone, and free androgen index.

Eyupoglu ND, Caliskan Guzelce E, Acikgoz A, et al. Clin Endocrinol (Oxf), 2019. PMID 31556132

2018 / Crossover trial

Curcumin reduces intestinal damage and physiological strain during exertional heat stress.

Eight non-heat-acclimated humans ran for 60 minutes in hot conditions after 3 days of 500 mg/day curcumin or placebo. Intestinal fatty acid-binding protein increased less with curcumin (18% to 58%) than placebo (33% to 87%). Placebo triggered significant rises in TNF-α and IL-10 (P < 0.01), whereas curcumin prevented significant changes. Curcumin also lowered the physiological strain index between 40 and 60 minutes of exercise (P < 0.01).

Szymanski MC, Gillum TL, Gould LM, et al. J Appl Physiol (1985), 2018. PMID 28935827

2018 / Randomized crossover trial

Traditional Malian sorghum and millet foods exhibited substantially slower gastric emptying than other staples.

In a crossover trial, 14 healthy volunteers in Mali tested gastric emptying rates of eight starchy staples using a carbon-13 octanoic acid breath test, followed by a 6-volunteer validation study. Traditional sorghum and millet foods showed gastric half-emptying times approximately twice as long as white rice, potato, or pasta (p < 0.0001). Pre-test assessments ranked millet couscous and rice as more filling, aligning with postprandial hunger ratings.

Cisse F, Erickson DP, Hayes AMR, et al. Nutrients, 2018. PMID 29373493

2018 / Double-blind, randomized, placebo-controlled trial

Amla tablets significantly reduced the frequency and severity of heartburn and regurgitation compared to placebo in patients with non-erosive reflux disease.

A double-blind, randomized, placebo-controlled trial evaluated the efficacy of Amla (Phyllanthus emblica L.) tablets in 68 patients with non-erosive reflux disease. Participants took two 500 mg Amla tablets or placebo twice daily after meals for 4 weeks. Heartburn and regurgitation frequencies significantly dropped in both groups (P < 0.001), but repeated measures logistic regression demonstrated a significantly greater reduction in the frequency and severity of both heartburn and regurgitation in the Amla group compared to placebo (P < 0.001).

Karkon Varnosfaderani S, Hashem-Dabaghian F, Amin G, et al. J Integr Med, 2018. PMID 29526236

2018 / Randomized controlled trial

Vegan fecal microbiota transplants did not lower TMAO production in metabolic syndrome.

Twenty men with metabolic syndrome received either autologous or lean vegan-donor fecal transplants. After two weeks, vegan-donor transplants altered microbial community structure toward a vegan profile in some participants. However, the intervention caused no functional changes in TMAO synthesis from choline or carnitine, aortic radiotracer uptake, or cytokine generation from isolated immune cells.

Smits LP, Kootte RS, Levin E, et al. J Am Heart Assoc, 2018. PMID 29581220